TABRECTA 150 mg/1

TABRECTA 150 mg is a film-coated tablet used for targeted therapy. It contains capmatinib, a medication prescribed for specific conditions. Learn more about its uses and effects.

TABRECTA 150 mg is primarily used in targeted therapy for certain types of cancer. It works by inhibiting specific proteins that contribute to cancer cell growth. Patients often wonder, 'What is TABRECTA used for?' This medication is designed to interfere with the growth and spread of cancer cells.

Common effects of TABRECTA 150 mg may include nausea, vomiting, and fatigue. Some users also report diarrhea and swelling in the limbs. These effects can vary from person to person, and it's important to discuss any concerns with a healthcare provider.

TABRECTA 150 mg should be handled with care. It is essential to follow the prescribed dosage and administration instructions. Patients should avoid breaking or crushing the tablets unless directed. Always store the medication in a cool, dry place away from children and pets.

TABRECTA 150 mg may interact with certain medications, including those that affect liver enzymes. It is crucial to inform your healthcare provider about all medications you are taking. Alcohol and other substances may also interact with TABRECTA, so it's important to discuss any potential interactions with a healthcare professional.